Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Home vs Clinic Cancer Therapy in Black Men With Advanced/Metastatic Prostate Cancer
NCT07073794Phase 2Recruiting
- Sponsor
- Mayo Clinic
- Start
- Aug 2025
- Primary completion
- Aug 2028
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in prostate cancer (PCa), sponsored by Mayo Clinic. Primary endpoints: Patient rating of overall cancer care experience - CAHPS at 48 weeks, Patient preferences regarding the location of cancer treatment delivery at 48 weeks and 3 more. Started Aug 2025; status: recruiting.
02
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT07073794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07073794.